Keyphrases
Risperidone
100%
Pharmacokinetics
100%
Genetic Variants
33%
Selective Serotonin Reuptake Inhibitors
33%
Pharmacodynamics
22%
Obstetrics
22%
Active Metabolite
22%
Clinical Outcomes
22%
Concentration Ratio
22%
Mentorship
22%
Plasma Concentration
22%
Pregnant Women
22%
Umbilical Cord
22%
Bipolar Disorder
22%
Pharmacokinetics-pharmacodynamics (PK-PD)
11%
Cerebrospinal Fluid Samples
11%
Umbilical Cord Blood
11%
Maternal Plasma
11%
ABCB1 Genotype
11%
CYP2D6 Genotype
11%
Inter-individual Variability
11%
Intraindividual Variability
11%
Co-primary
11%
Drug Toxicity
11%
Phenotypic Relationships
11%
Schizophrenia Treatment
11%
Pharmacology
11%
Dosing Algorithm
11%
Evidence-based
11%
Pregnancy Complications
11%
Pharmacokinetic Changes
11%
Psychiatry
11%
ATP Binding Cassette Subfamily B Member 1 (ABCB1)
11%
Mood Symptoms
11%
Pharmacogenomics
11%
Genetic Variation
11%
Medication Dosing
11%
Metabolism
11%
During Pregnancy
11%
Drug Efficacy
11%
Schizophrenia
11%
Second-generation Antipsychotics
11%
Elimination Clearance
11%
Preterm Birth
11%
Enzymatic Activity
11%
Additional Training
11%
Schizophrenia Symptoms
11%
Pharmacotherapy
11%
Career Development Awards
11%
Hands-on Training
11%
Research Career Development
11%
Placental Abnormalities
11%
Increased Mortality
11%
Preeclampsia
11%
Low Birth Weight
11%
High-risk Pregnancy
11%
Severe Mental Illness
11%
Transporter Genes
11%
NICHD
11%
Psychiatrists
11%
Resubmission
11%
Poor Birth Outcomes
11%
Mental Health Outcomes
11%
Cerebrospinal Fluid
11%
Cord Plasma
11%
Patient-centered Research
11%
Interdisciplinary Training
11%
Depression during Pregnancy
11%
Pregnancy Outcome
11%
Depressive Symptoms
11%
Biochemistry, Genetics and Molecular Biology
Risperidone
100%
Pharmacokinetics
100%
Genetic Divergence
44%
Pharmacodynamics
33%
Selective Serotonin Reuptake Inhibitor
33%
Concentration Ratio
22%
Blood Level
22%
Metabolite
22%
Genotyping
11%
Liquid
11%
Transporter Genes
11%
Metabolic Pathway
11%
Pharmacogenomics
11%
Toxicity During Pregnancy
11%
Cerebrospinal Fluid-to-Plasma Ratio
11%
Mental Health
11%
Drug Toxicity
11%
Drug Efficacy
11%
Genetic Variation
11%
Enzyme Activity
11%
Typical Antipsychotic
11%
Low Birth Weight
11%
CYP2D6
11%
Blood Plasma
11%
Omeprazole
11%
Pharmacology, Toxicology and Pharmaceutical Science
Risperidone
100%
Pharmacokinetics
100%
Pharmacodynamics
33%
Selective Serotonin Reuptake Inhibitor
33%
Active Metabolite
22%
Bipolar Disorder
22%
Depression
11%
Pharmacotherapy
11%
Elimination
11%
Omeprazole
11%
Pharmacogenomics
11%
Toxicity During Pregnancy
11%
Pregnancy Complication
11%
Recurrent Disease
11%
Preeclampsia
11%
Psychotropic Agent
11%
CYP2D6
11%
Premature Labor
11%
Side Effect
11%
Typical Antipsychotic
11%
Low Birth Weight
11%